Event-free and overall survival of patients observed in the study. Kaplan-Meier plots of (A) event-free and (B) overall survival, relative to disease status at HCT, after HLA-haploidentical HCT in patients receiving a conditioning therapy containing reduced-dose busulfan, fludarabine, and ATG.